你即將離開本站

並前往https://www.nytimes.com/2019/08/07/health/novartis-fda-gene-therapy.html

Novartis CEO Defends Company's Decision to Withhold False ...

Novartis and the F.D.A. have said the falsified data did not affect the safety, quality or efficacy of Zolgensma, a therapy that treats a ...

確定！ 回上一頁

查詢 「Zolgensma FDA」的人也找了：

  1. Zolgensma
    2.
  2. START zolgensma
    3.
  3. FDA approved CAR T
    4.
  4. Zolgensma label
    5.
  5. Zolgensma price
    6.
  6. Zolgensma Novartis
    7.
  7. Zolgensma Mechanism
    8.
  8. FDA-approved stem cell therapy
    9.